Ufp Technologies (UFPT) Non-Current Assets (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Non-Current Assets came in at $447.0 million in Q2 2026, up 0.85% on a YoY basis from $443.3 million in Q2 2025, and down 0.79% quarter-over-quarter from $450.6 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Non-Current Assets (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Non-Current Assets for 17 consecutive years, with $447.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 0.85% year-over-year to $447.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 billion (up 3.14% YoY), and the FY2025 full-year result was $454.1 million, up 4.61% from the prior year.
- Non-Current Assets eased to $447.0 million in Q2 2026 per UFPT's latest filing, from $450.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $454.8 million in Q3 2025 and bottomed at $257.1 million in Q1 2024.
- Historically, Non-Current Assets has averaged $343.0 million across 5 years, with a median of $267.1 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets soared 105.9% in 2022, then fell 3.13% in 2023.
- Over 5 years, Non-Current Assets stood at $261.8 million in 2022, then slipped by 0.89% to $259.5 million in 2023, then surged by 67.26% to $434.0 million in 2024, then advanced by 4.61% to $454.1 million in 2025, then fell by 1.55% to $447.0 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $447.0 million, $450.6 million, and $454.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 447.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 447.02 Mn |
| Mar 31, 2026 | 450.58 Mn |
| Dec 31, 2025 | 454.08 Mn |
| Sep 30, 2025 | 454.85 Mn |
| Jun 30, 2025 | 443.27 Mn |
| Mar 31, 2025 | 436.76 Mn |
| Dec 31, 2024 | 434.05 Mn |
| Sep 30, 2024 | 437.50 Mn |
| Jun 30, 2024 | 260.24 Mn |
| Mar 31, 2024 | 257.14 Mn |
| Dec 31, 2023 | 259.50 Mn |
| Sep 30, 2023 | 259.34 Mn |
| Jun 30, 2023 | 260.92 Mn |
| Mar 31, 2023 | 263.87 Mn |
| Dec 31, 2022 | 261.85 Mn |
| Sep 30, 2022 | 258.07 Mn |
| Jun 30, 2022 | 269.35 Mn |
| Mar 31, 2022 | 264.91 Mn |
| Dec 31, 2021 | 246.81 Mn |
| Sep 30, 2021 | 129.55 Mn |